Evidence map›Paper›PMID 42737501›Full record

ArticleInternational journal of molecular sciences2026

Marina V Nemtsova, Maria V Makarova, Anastasiia M Danishevich, Maria M Byakhova, Olesya S Mishina, Alevtina E Kiseleva, Maxim S Belenikin, Anastasia A Krinitsina, Olesya V Sagaydak, Anna B Semenova and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marina V NemtsovaEvogen LLC, Fotiyevoy St., 6, b.1, 119333 Moscow, Russia.
Maria V MakarovaEvogen LLC, Fotiyevoy St., 6, b.1, 119333 Moscow, Russia.ORCID 0000-0003-1581-9118
Anastasiia M DanishevichMoscow Clinical Scientific Centre Named After A.S. Loginov, Novogireevskaya St., 1 p. 1, 111123 Moscow, Russia.
Maria M ByakhovaMoscow City Clinical Hospital Named After S.S. Yudin, Kolomensky pr., 4, 115446 Moscow, Russia.
Olesya S MishinaEvogen LLC, Fotiyevoy St., 6, b.1, 119333 Moscow, Russia.ORCID 0000-0002-4845-4701
Alevtina E KiselevaFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov of the Ministry of Health of Russian Federation, Trubetskaya St., 8 p. 2, 119991 Moscow, Russia.
Maxim S BelenikinEvogen LLC, Fotiyevoy St., 6, b.1, 119333 Moscow, Russia.
Anastasia A KrinitsinaEvogen LLC, Fotiyevoy St., 6, b.1, 119333 Moscow, Russia.
Olesya V SagaydakEvogen LLC, Fotiyevoy St., 6, b.1, 119333 Moscow, Russia.
Anna B SemenovaMoscow City Clinical Hospital Named After S.S. Yudin, Kolomensky pr., 4, 115446 Moscow, Russia.
Natalia A BodunovaMoscow Clinical Scientific Centre Named After A.S. Loginov, Novogireevskaya St., 1 p. 1, 111123 Moscow, Russia.
Igor E KhatkovMoscow Clinical Scientific Centre Named After A.S. Loginov, Novogireevskaya St., 1 p. 1, 111123 Moscow, Russia.
Irina A DemidovaMoscow City Oncology Hospital No. 62, Bolshoy Boulevard, 67, Skolkovo Innovation Center, 121205 Moscow, Russia.
Aleksey S TsukanovRyzhikh National Medical Research Centre for Coloproctology, Salama Adil Str., 2, 123423 Moscow, Russia.ORCID 0000-0001-8571-7462
Vsevolod N GalkinMoscow City Clinical Hospital Named After S.S. Yudin, Kolomensky pr., 4, 115446 Moscow, Russia.
Saida M GadzhyevaMoscow Healthcare Department, Oruzheyniy per., 43, 127006 Moscow, Russia.

Funding

Moscow Healthcare Department The study was funded by a grant from the Moscow Healthcare Department (agreement on the provision of a grant in the form of a subsidy from the budget of Moscow to Moscow City Clinical Hospital named after S.S. Yudin 1022/2 dated 24.12.2020; agreements on
6 · The paper itself

Abstract

While pathogenic germline

Indexed as

Checkpoint Kinase 2Genetic Predisposition to DiseaseGerm-Line MutationNeoplasmsAdultFemaleHumansMaleMiddle AgedWhole Genome SequencingCheckpoint Kinase 2CHEK2 protein, humanc.1100delc.444+1G>Ac.470T>Ccancer riskCHEK2hereditary breast cancerhereditary cancer syndromes (HCS)I157Twhole genome sequencing (WGS)

Identifiers

PMID42737501
PMCPMC13566504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.